Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.692.662.943.124.01

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 2.69 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.69
Mar20232.66
Mar20222.94
Mar20213.12
Mar20204.01

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94
-5.77
Mar2021 3.12
-22.19
Mar2020 4.01 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹700.3 Cr 2.3% -1.4% -56.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr 0.8% 7.2% 22.2% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 0.7% 11% 53.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2% 4.6% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -1.6% 2.8% 24.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.4% 0.7% -5.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

2.3%

-1.4%

-56.4%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses